2
Announcements
Trials
Browse
Landscape
Phase
Phase 2
2
Status
Recruiting
2
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Gastrointestinal
2
Conditions
Nasopharyngeal Carcinoma
39
Carcinoma, Non-Small-Cell Lung
30
Carcinoma, Hepatocellular
23
Esophageal Squamous Cell Carcinoma
22
Triple Negative Breast Neoplasms
19
Breast Neoplasms
18
Squamous Cell Carcinoma of Head and Neck
17
Advanced Solid Tumor
17
Melanoma
15
Stomach Neoplasms
14
Small Cell Lung Carcinoma
13
Colorectal Neoplasms
13
Uterine Cervical Neoplasms
12
Neoplasms
10
Carcinoma, Transitional Cell
10
Carcinoma, Renal Cell
10
Recurrence
9
Solid Tumor
7
Sarcoma
7
Neoplasm Metastasis
7
Liver Neoplasms
7
Head and Neck Neoplasms
7
Esophageal Neoplasms
6
Urinary Bladder Neoplasms
5
Rectal Neoplasms
5
Advanced Solid Tumors
5
Pancreatic Neoplasms
4
Laryngeal Neoplasms
4
Hypopharyngeal Neoplasms
4
Cholangiocarcinoma
4
Interventions
pembrolizumab
10
Nivolumab
9
Ipilimumab
4
avelumab
3
Neoadjuvant Therapy
3
toripalimab
2
sintilimab
2
durvalumab
2
atezolizumab
2
Specimen Handling
2
Immune Checkpoint Inhibitors
2
Celecoxib
2
tislelizumab
1
spartalizumab
1
relatlimab
1
regorafenib
1
fludarabine phosphate
1
fludarabine
1
dostarlimab
1
denileukin diftitox
1
danvatirsen
1
camrelizumab
1
XELOX
1
Taxes
1
Surgical Procedures, Operative
1
Radiation Dose Hypofractionation
1
Paclitaxel
1
Oxaliplatin
1
Megestrol Acetate
1
Medroxyprogesterone Acetate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Turcot syndrome
×
toripalimab
×
Clear all
NCT06903858
2026-05-22
PICC-3
Sun Yat-sen University
Phase 2
Recruiting
105 enrolled
NCT03926338
2025-11-20
PICC
Sun Yat-sen University
Phase 2
Recruiting
270 enrolled